[How we diagnose and treat chronic lymphocytic leukemia].
作者信息
Li J Y, Xu W
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 Jul 14;39(7):529-532. doi: 10.3760/cma.j.issn.0253-2727.2018.07.001.
Abstract
摘要
相似文献
1
[How we diagnose and treat chronic lymphocytic leukemia].[我们如何诊断和治疗慢性淋巴细胞白血病]
Zhonghua Xue Ye Xue Za Zhi. 2018 Jul 14;39(7):529-532. doi: 10.3760/cma.j.issn.0253-2727.2018.07.001.
2
A rare association of chronic lymphocytic leukemia with c-ANCA-positive Wegener's granulomatosis: a case report.慢性淋巴细胞白血病与抗中性粒细胞胞浆抗体阳性的韦格纳肉芽肿罕见关联：一例报告
World J Surg Oncol. 2016 May 16;14:145. doi: 10.1186/s12957-016-0901-x.
3
Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.Richter综合征伴慢性淋巴细胞白血病/小淋巴细胞淋巴瘤细胞的滤泡浸润，酷似滤泡性淋巴瘤。
Int J Surg Pathol. 2014 Dec;22(8):736-43. doi: 10.1177/1066896913509011. Epub 2013 Nov 18.
4
Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者亲属中单克隆B细胞淋巴细胞增多症的发生率。
Colomb Med (Cali). 2016 Jun 30;47(2):81-6.
5
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.B细胞受体抑制剂在慢性淋巴细胞白血病患者治疗中的作用。
Haematologica. 2015 Dec;100(12):1495-507. doi: 10.3324/haematol.2014.119123.
6
Concomitant Venetoclax and Imatinib for Comanaging Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia: A Case Report.维奈托克与伊马替尼联合治疗慢性淋巴细胞白血病和慢性髓性白血病：病例报告
J Natl Compr Canc Netw. 2023 Feb;21(2):102-107. doi: 10.6004/jnccn.2022.7069.
7
Monoclonal antibodies in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的单克隆抗体
Expert Rev Anticancer Ther. 2006 Sep;6(9):1231-8. doi: 10.1586/14737140.6.9.1231.
8
US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation.美国食品和药物管理局批准用于慢性淋巴细胞白血病患者的布鲁顿酪氨酸激酶抑制剂：临床试验设计和证据生成中的潜在效率低下。
Cancer. 2020 Oct 1;126(19):4270-4272. doi: 10.1002/cncr.33058. Epub 2020 Jul 9.
9
Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia.记忆T细胞在慢性淋巴细胞白血病病理生理学中的作用。
Rev Bras Hematol Hemoter. 2014;36(1):60-4. doi: 10.5581/1516-8484.20140015.
10
Changing landscape of frontline therapy in chronic lymphocytic leukemia.慢性淋巴细胞白血病一线治疗的格局变化。
Leuk Lymphoma. 2020 Mar;61(3):525-535. doi: 10.1080/10428194.2019.1688321. Epub 2019 Nov 15.
本文引用的文献
1
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.CD200 表达在套细胞淋巴瘤中鉴定出一个独特的亚组患者，这些患者具有频繁的 IGHV 突变、SOX11 表达缺失和惰性临床病程。
Mod Pathol. 2018 Feb;31(2):327-336. doi: 10.1038/modpathol.2017.135. Epub 2017 Oct 6.
2
Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.中国653例B细胞慢性淋巴细胞增殖性疾病患者的谱系及免疫表型分析：一项单中心研究
Hematol Oncol. 2018 Feb;36(1):121-127. doi: 10.1002/hon.2461. Epub 2017 Jul 28.
3
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.一线苯达莫司汀和利妥昔单抗联合化疗与氟达拉滨、环磷酰胺和利妥昔单抗治疗晚期慢性淋巴细胞白血病（CLL10）患者：一项国际、开放标签、随机、III 期、非劣效性临床试验。
Lancet Oncol. 2016 Jul;17(7):928-942. doi: 10.1016/S1470-2045(16)30051-1. Epub 2016 May 20.
4
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.国际慢性淋巴细胞白血病预后指数（CLL-IPI）：个体患者数据的荟萃分析。
Lancet Oncol. 2016 Jun;17(6):779-790. doi: 10.1016/S1470-2045(16)30029-8. Epub 2016 May 13.
5
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
6
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.在复发的慢性淋巴细胞白血病中使用维奈托克靶向BCL2
N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. Epub 2015 Dec 6.
7
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.伊布替尼作为慢性淋巴细胞白血病患者的初始治疗方法。
N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6.
8
Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.CD200和CD148在白血病性B细胞慢性淋巴细胞增殖性疾病中的表达模式及其在鉴别诊断中的潜在价值。
Leuk Lymphoma. 2015;56(12):3329-35. doi: 10.3109/10428194.2015.1030642. Epub 2015 Jun 19.
9
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.依鲁替尼联合利妥昔单抗治疗复发慢性淋巴细胞白血病。
N Engl J Med. 2014 Mar 13;370(11):997-1007. doi: 10.1056/NEJMoa1315226. Epub 2014 Jan 22.
10
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.奥滨尤妥珠单抗联合苯丁酸氮芥治疗伴有合并症的 CLL 患者。
N Engl J Med. 2014 Mar 20;370(12):1101-10. doi: 10.1056/NEJMoa1313984. Epub 2014 Jan 8.
Zotero 插件